Europe
United Kingdom
Europe
United Kingdom

The 'go to' European specialist pharma company

Pipeline

We operate in three core therapy areas – gastroenterology, hepatology, critical and supportive care.

 

Compound

Mechanism of action

Therapy area

Area under investigation 

Phase

Originator / Partner

NPJ5007

 

Personalised cell based product

Gastroenterology

Faecal incontinence

II

Innovacell

XIFAXAN®

Non-absorbed broad spectrum antibiotic

Gastroenterology

Crohn's Disease

III

Alfa Wassermann

PLENVU®

(NER 1006)

Osmotic laxative

Gastroenterology

Bowel cleansing

III

Norgine B.V.

CAMETOR®/

OBLEAN®

Lipase inhibitor

Gastroenterology

Weight loss / obesity

Registration / Launch

Norgine B.V.

LYMPHOSEEK®

Tilmanocept

Supportive Care

Diagnostic medicine in patients with cancer to identify sentinel lymph nodes Registration / Launch

SpePharm AG

 
June 2016. GL/COR/0616/0071